 On behalf of the whole team, Professor Helen Dewey, Patrick Kearney, Catherine Bazar, Professor Butts-Cuven, Ellen Young, Denise Driscoe, and Professor Danny Eckert, I would like to thank the Brain Foundation and other donors for this prestigious and competitive gift that we were awarded. So just to give a bit of background, I am a neurologist from Brazil. I came to Australia initially in 2014 for my PhD at UNS Southern Europe, where my PhD was on neuroscience. And the idea for this project was a continuation of my PhD. And the reason for this research is because MS patients are often presenting with fatigue, which is a very common and debilitating feature that happens in all multiple sclerosis patients. So obstructive sleep apnea happens in about 20% of all MS patients prior to diagnosis. And during disease course, it can build up to up to 90%. And traditionally, MS patients do not have the traditional risk factors for obstructive sleep apnea, such as overweight, middle-aged, male, so which implies that perhaps the neuroinflammation that happens in those patients may play a role in upper airway collapsibility during sleep. So to assess those patients, I'll be using two simple tools. One is the stopband questionnaire, which is a validated questionnaire to measure the risk of obstructive sleep apnea in general population. In MS patients, it has shown that the questionnaire itself can only identify about 56% of those patients. And I'll be also using another simple tool, which is the upper airway sensation testing with monofilaments that can identify up to 50% of patients with high risk of airway collapsibility during sleep. So during the study, I'll be looking at a cohort. This is a pilot study of 30 patients that will be divided or be categorized based on the stopband questionnaire on low versus high risk of obstructive sleep apnea. They'll be assessed with the questionnaire as well, and all of them will be followed up with the gold standard sleep diagnosis or polysynography. So at the end of it all, I'll be comparing the results. And we hypothesize that the combination of those two simple tools will increase the prediction of obstructive sleep apnea in this cohort of patients. And the ultimate goal of this study, obviously, it's a long-term research that is building data for more research, but we'll be aiming in the future to look at larger cohorts. And the goal of this study is we hope that improving the diagnosis of obstructive sleep apnea, we can better manage fatigue in those patients. And also, in the light of the recent changes in Medicare billing for the sleep studies, we also hope that combining those two tools, we can be simply or easily used in the clinical practice. We can identify those patients and reduce the burden to public health costs. So I would like to thank all the donors, all the guests present here, and the organizing committee for this gift. Thank you.